Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

BACKGROUND: Growing evidence has indicated that tumor biomarkers, including cytokeratin 19 fragment antigen 21–1 (Cyfra21–1), carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4 (CA72–4), carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) were reported to be common...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Yang, Yuchong, Huang, Xuanzhang, Zhou, Likun, Deng, Ting, Ning, Tao, Liu, Rui, Zhang, Le, Bai, Ming, Zhang, Haiyang, Li, Hongli, Ba, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544972/
https://ncbi.nlm.nih.gov/pubmed/31151431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5755-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados